Should You Buy Oncology Pharma Inc (ONPH) Stock on Wednesday?

The market has been down on Oncology Pharma Inc (ONPH) stock recently. ONPH gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Oncology Pharma Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ONPH!

See Full ONPH Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ONPH Stock Today?

Oncology Pharma Inc (ONPH) stock is trading at $4.95 as of 10:57 AM on Wednesday, Dec 1, a drop of -$0.49, or -9.01% from the previous closing price of $5.44. The stock has traded between $4.81 and $5.40 so far today. Volume today is below average. So far 95,513 shares have traded compared to average volume of 337,134 shares. To screen for more stocks like Oncology Pharma Inc click here.

More About Oncology Pharma Inc

Oncology Pharma Inc is an oncology company. It is engaged in the development, manufacturing, and commercialization of therapeutics. Its NanoSmart's platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. The company has developed a novel drug delivery vehicle that targets many types of cancer. Click Here to get the full Stock Report for Oncology Pharma Inc stock.